Douglas W. Blayney

A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell Leukemia

V. S. Kalyanaraman, M. G. Sarngadharan, Marjorie Robert-Guroff et al. · Science · 1982 · 1.2K citations

Life Sciences, Immunology, Molecular Biology +17

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

Gabriel N. Hortobágyi, Richard L. Theriault, Lester Porter et al. · New England Journal of Medicine · 1996 · 1K citations

Medicine, Cancer Biology, Oncology +14

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Lowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins et al. · Journal of Clinical Oncology · 2015 · 905 citations

Public Affairs, Health Policy, Oncology +17

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

Nancy U. Lin, Ann Vanderplas, Melissa E. Hughes et al. · Cancer · 2012 · 706 citations · Full text

Medicine, Oncology, Breast Oncology +12

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

Lowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins et al. · Journal of Clinical Oncology · 2016 · 655 citations

Pharmacy, Oncology, Pharmacoeconomics +13